Post-resection Treatment of Large Colon Polyps
Completed · Not applicable
Conditions studied: Recurrence
In brief
Patients who have provided informed consented and are scheduled to undergo endoscopic mucosal resection (EMR) of lesions 15mm and larger will be randomized to STSC (80 W, Effect 5) vs APC (preferred settings) vs No Treatment of the perimeter of the EMR site.
Key facts
- Study ID
- NCT03654209
- Run by
- Indiana University
- People needed
- 384
- Starts
- 2018-10-16
- Expected to finish
- 2022-12-14
- Last updated by the study team
- 2024-01-05
Who can join
Age: 25 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- 25 years and older
- Ability to provide informed consent
- Undergoing colonoscopy for screening, surveillance, diagnostic reasons, or removal of a lesion
You may not qualify if…
- Pedunculated lesions
- Inflammatory bowel disease
- Inability to provide informed consent
- Lesions less than 15mm in largest dimension
Where it is running
- Sibley Memorial Hospital — Washington D.C., District of Columbia, United States
- AdventHealth Orlando — Orlando, Florida, United States
- Indiana University Health University Hospital — Indianapolis, Indiana, United States
- Spring Mill Medical Center — Indianapolis, Indiana, United States
- The University of Kansas Medical Center — Kansas City, Kansas, United States
- The Johns Hopkins Hospital — Baltimore, Maryland, United States
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
- NYU Langone Medical Center — New York, New York, United States
- The Mount Sinai Hospital — New York, New York, United States
- Penn State Health Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.